Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O00506
UPID:
STK25_HUMAN
Alternative names:
Ste20-like kinase; Sterile 20/oxidant stress-response kinase 1
Alternative UPACC:
O00506; A8K6Z3; A8K7D2; B7Z9K1; Q15522; Q5BJF1
Background:
Serine/threonine-protein kinase 25, also known as Ste20-like kinase and Sterile 20/oxidant stress-response kinase 1, is a crucial enzyme in cellular response to environmental stress. It primarily activates in response to oxidant stress, targeting the Golgi apparatus to regulate protein transport, cell adhesion, and polarity complexes, which are vital for cell migration.
Therapeutic significance:
Understanding the role of Serine/threonine-protein kinase 25 could open doors to potential therapeutic strategies.